US and EU industry issue response to coronavirus
As COVID-19 continues spreading, regulatory agencies alongside industry representatives coordinate their efforts to overcome the rising challenges.
Archives for February 26, 2020
Female participation up, diversity rates down in 2019 approved drugs’ trials
US FDA’s 2019 Drugs Trials Snapshots show female participation in clinical trials of the drugs approved during the past year increased, although ethnic diversity remains an issue.